Avet Pharma specializes in products covering a number of therapeutic categories, including, but not limited to, cardiovascular disease, metabolic disease, anti-infective, and pain management in oral solids and liquids as well as injectable dosage forms.

Our globally integrated supply network features U. S. based product manufacturing and packaging capabilities, as well as strategically outsourced product development and manufacturing to U.S. FDA approved partner organizations in North America, Europe, and Asia.  Avet is proud to have a robust pipeline of generic products, and we plan to introduce new product offerings as our pipeline matures through the regulatory approval process.

A strong commercial operations and sales team, combined with a global supply chain network and presence in both the U.S. and Asia, provide us with access to cost-effective development, materials, and manufacturing capacity. This allows Avet to be efficient and flexible in business development while prioritizing commercial excellence, customer service and quality.